CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for HYTN Innovations Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

HYTN Innovations Inc
Unit 303 - 890 Clement Ave
Phone: (604) 689-2454p:604 689-2454 KELOWNA, BC  V1Y 7E4  Canada Ticker: HYTNHYTN
Business Summary
HYTN Innovations Inc. is a Canada-based pharmaceutical company. The Company is specialized in the formulation, manufacturing, marketing, and sale of products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids and psilocybe-derived tryptamines. It is engaged in the development of the sparkling tetrahydrocannabinol and the cannabidiol beverage business. Its product and services include GMP Cannabis Processing, GMP Psilocybin Mushroom Manufacturing, GMP Active Pharmaceutical Ingredient (API) Fabrication, Cannabis Consumer Packaged Goods, and Elevation Technology. The Company enables global market access for non-sterile pharmaceuticals. It has a manufacturing facility based in Kelowna, British Columbia. The Company’s subsidiaries include HYTN Innovations Inc., HYTN Beverage Corp, HYTN Cannabis Inc., 1306562 B.C. Ltd., and Prism Scientific Labs Inc.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20259/30/2024Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2086 Bottled and canned soft drinks and carbonated waters

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director ElliotMckerr 2/17/2022 2/17/2022
Chief Financial Officer, Company Secretary PaulMore 2/17/2022 2/17/2022
Chief Operating Officer, Director JasonBroome 2/17/2022 2/17/2022
Independent Director Eli Seamus S.Dusenbury 10/22/2021 10/22/2021

Business Names
Business Name
HYTN
Prism Scientific Labs Inc.

General Information
Outstanding Shares: 93,708,107 (As of 6/30/2025)
Stock Exchange: CNQ
Fax Number: (604) 689-2435


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, December 12, 2025